Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line
Fierce Pharma
Wednesday, August 28, 2024 - 11:46am
tags:
Novartis, Lindy Biosciences, drug delivery
Neurocrine's drug cuts schizophrenia symptoms in mid-stage study
Reuters
Wednesday, August 28, 2024 - 11:42am
tags:
Neurocrine Biosciences, schizophrenia, clinical trials, NBI-1117568
After an FDA rejection, here’s what’s next in the psychedelics pipeline
BioPharma Dive
Wednesday, August 28, 2024 - 11:41am
tags:
psychedelics, FDA, Lykos Therapeutics, COMPASS Pathways, Incannex Healthcare, MindMed
Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer
First Word Pharma
Wednesday, August 28, 2024 - 11:38am
tags:
Bayer, NextRNA, IncRNAs, cancer
Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research unit
Fierce Biotech
Wednesday, August 28, 2024 - 11:36am
tags:
Genentech, Roche, layoffs, California
Feds killed plan to curb medicare advantage overbilling after industry opposition
Medical Marketing and Media
Wednesday, August 28, 2024 - 11:35am
tags:
Medicare, overbilling, patients
After obesity, Pfizer and Flagship pick 2 more targets for multibillion-dollar partnership
Fierce Biotech
Wednesday, August 28, 2024 - 11:33am
tags:
Pfizer, Flagship Pioneering, Quotient, ProFound Therapeutics
Novartis builds case for Leqvio with monotherapy data
Pharmaphorum
Wednesday, August 28, 2024 - 11:29am
tags:
Novartis, Leqvio, cholesterol, clinical trials
Jazz, Hikma must face 'reverse payment' claims over narcolepsy drug
Reuters
Tuesday, August 27, 2024 - 10:32pm
tags:
Jazz Pharma, Hikma, Xyrem, reverse payments, legal
After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly
Fierce Pharma
Tuesday, August 27, 2024 - 8:11pm
tags:
Endo, Pharma CEOs, Blaise Coleman
Q2 2024 update: future of work related hiring actvity in the pharma industry
Clinical Trials Arena
Tuesday, August 27, 2024 - 8:10pm
tags:
hirings, pharma industry
Q2 2024 update: cell & gene therapy related hiring actvity in the pharma industry
Clinical Trials Arena
Tuesday, August 27, 2024 - 8:09pm
tags:
hirings, cell therapy, gene therapy
Delaware top court will hear drugmakers' appeal to end Zantac lawsuits
Reuters
Tuesday, August 27, 2024 - 8:08pm
tags:
GSK, legal, Zantac, Delaware
AstraZeneca investment to increase biologic capacity in Sweden
European Pharmaceutical Review
Tuesday, August 27, 2024 - 8:07pm
tags:
AstraZeneca, Sweden, drug manufacturing
Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount
Fierce Pharma
Tuesday, August 27, 2024 - 11:51am
tags:
Eli Lilly, Zebound, DTC
First real-world data for rVSV-ZEBOV vaccine supports use for future Ebola outbreaks
Clinical Trials Arena
Tuesday, August 27, 2024 - 11:38am
tags:
Merck, vaccines, rVSV-ZEBOV, ebola virus, real world data
Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond
Fierce Biotech
Tuesday, August 27, 2024 - 11:34am
tags:
DualityBio, China, Hong Kong, IPOs, BioNTech
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study
BioSpace
Tuesday, August 27, 2024 - 11:32am
tags:
Novo Nordisk, cardiovascular disease, Medicare, semaglutide, Wegovy, Ozempic
Spectral AI hits enrollment goal at burn centers for AI-powered assessment tech
Clinical Trials Arena
Tuesday, August 27, 2024 - 11:31am
tags:
Spectral AI, clinical trials, burns, Medtech, artificial intelligence
Lilly launches smallest single-dose vials of Zepbound for $399
Reuters
Tuesday, August 27, 2024 - 11:16am
tags:
Eli Lilly, Zepbound

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.